#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Prostate cancer Obesity Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Malignant melanoma Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Rett syndrome Amyotrophic lateral sclerosis gene carrier Exudative retinopathy Cardiac sarcoidosis Myeloid leukaemia Primary amyloidosis Hidradenitis Fusarium infection Encephalitis autoimmune Thromboangiitis obliterans Oesophageal squamous cell carcinoma stage II Dupuytren's contracture Transitional cell carcinoma Peritoneal neoplasm Osteochondrodysplasia More trials…

    Learn about Rare Diseases

    Bronchiolitis obliterans syndrome – Basic Information Nephroblastoma – Diagnostics Prader-Willi syndrome – Treatment Mucopolysaccharidosis Sarcoma – Life with Disease Ewing’s sarcoma metastatic – Life with Disease Hereditary neuropathic amyloidosis – Life with Disease Primary biliary cholangitis – Basic Information Synovial sarcoma recurrent – Life with Disease Activated PI3 kinase delta syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Talquetamab Tamoxifen Clobetasol Glepaglutide Cefuroxime Human Serum Albumin 5% Anb032 Carbetocin Omeprazole Bexotegrast Mosaic Hbcoreag Amsacrine Polatuzumab Vedotin ULTEVURSEN CICLOPIROX Tetracaine Hydrochloride Mepacrine Regn7257 YOHIMBINE HYDROCHLORIDE Amb-05X More therapies…

    Learn about Your Condition

    Oesophageal atresia Marfan's syndrome Hepatitis D Colon cancer stage IV Chorioretinitis Immune-mediated renal disorder Lymphangioleiomyomatosis Trisomy 21 Ophthalmoplegia Haemorrhage Short-bowel syndrome Metastatic gastric cancer Progressive multiple sclerosis Skin papilloma Medulloblastoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Aarhus

  • A Study of ANX005 for Patients Recently Diagnosed with Guillain-Barré Syndrome to Evaluate How the Drug Works in the Body and Its Safety

    Recruiting

    3 1 1
    Investigated Drugs:
    • HUMANISED IGG4 MONOCLONAL ANTIBODY AGAINST C1Q
    Denmark France Spain
  • Study of semaglutide for weight loss in adults with type 1 diabetes and obesity

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Obesity
    • Type 1 diabetes mellitus
    Investigated Drugs:
    • Placebo
    • Semaglutide
    Denmark
  • Study of MK-1045 versus blinatumomab with tocilizumab in patients with relapsed or refractory B-cell acute lymphoblastic leukemia

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • B-cell type acute leukaemia
    Investigated Drugs:
    • Blinatumomab
    • Tocilizumab
    Denmark France Greece Italy The Netherlands Spain +1
  • Study on Oxygen Therapy and Drug Combination for Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Air, Medicinal
    • Fenoterol Hydrobromide
    • Ipratropium Bromide
    Denmark
  • Obrixtamig, Carboplatin, and Etoposide for First-Line Treatment of Advanced Extrapulmonary Neuroendocrine Carcinoma in DLL3-Positive Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Neuroendocrine carcinoma
    Investigated Drugs:
    • Igg-Like T Cell Engager Binding To Dll3 And Cd3
    • Carboplatin
    • Etoposide
    Austria Belgium Czechia Denmark Finland France +8
  • A Phase 3b Study of Guselkumab Compared with Risankizumab in Adults with Moderately to Severely Active Crohn’s Disease

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Risankizumab
    • Guselkumab
    Austria Belgium Czechia Denmark France Germany +7
1 2 3 … 101
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Cyclophosphamide Sodium Chloride Rituximab Dexamethasone Pembrolizumab Prednisolone Vincristine Sulfate Semaglutide Doxorubicin Hydrochloride Carboplatin Etoposide Cytarabine Tocilizumab Placebo Acetylsalicylic Acid Venetoclax Cisplatin Prednisone Human Normal Immunoglobulin Lenalidomide Dapagliflozin Methotrexate Bortezomib Pomalidomide Oxaliplatin Daratumumab Ifosfamide Paracetamol Apixaban Pyruvic Acid Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Acquired ATTR amyloidosis Acute coronary syndrome Acute HIV infection Acute kidney injury Acute lymphocytic leukaemia Acute myeloid leukaemia Acute myocardial infarction Acute respiratory failure Adrenal insufficiency Adrenogenital syndrome Adult T-cell lymphoma/leukaemia refractory Age-related macular degeneration Amyotrophic lateral sclerosis Anaesthesia Anal fistula Anaplastic large cell lymphoma T- and null-cell types Angiosarcoma Anti-glomerular basement membrane disease Antiphospholipid antibodies Aortic aneurysm Aortic stenosis Aortic valve replacement Arterial disorder Arteriosclerosis Asthma Atrial fibrillation Atrophic vulvovaginitis Atypical teratoid/rhabdoid tumour of CNS Autoimmune haemolytic anaemia B-cell lymphoma B-cell lymphoma refractory B-cell small lymphocytic lymphoma B-cell type acute leukaemia Bacterial infection Bile duct cancer Bladder cancer Bladder transitional cell carcinoma Brain abscess Brain neoplasm Brain stem glioma Breast cancer Breast cancer metastatic Bronchiectasis Bronchopulmonary dysplasia Caesarean section Cancer fatigue Cardiac amyloidosis Cardiac arrest Cardiac failure Cardiac failure acute Cardiac failure chronic Cardiomyopathy Cardiovascular disorder Central nervous system lymphoma Cerebrovascular accident Cerebrovascular accident prophylaxis Cervix carcinoma Childhood asthma Cholangitis sclerosing Chondrosarcoma Chronic coronary syndrome Chronic graft versus host disease Chronic inflammatory demyelinating polyradiculoneuropathy Chronic kidney disease Chronic lymphocytic leukaemia Chronic myeloid leukaemia Chronic obstructive pulmonary disease Chronic rhinosinusitis with nasal polyps Chronic spontaneous urticaria Clostridium difficile infection Colitis microscopic Colitis ulcerative Colon cancer Colorectal cancer Colorectal cancer metastatic Complex regional pain syndrome Congenital cystic kidney disease Corneal dystrophy Coronary artery bypass Coronary artery disease Coronavirus infection COVID-19 Crohn's disease Cutaneous lupus erythematosus Cutaneous T-cell lymphoma Cystic fibrosis Dedifferentiated liposarcoma Dementia Alzheimer's type Dermatitis atopic Dermatomyositis Device related infection Diabetes mellitus Diabetic nephropathy Diabetic neuropathy Diffuse large B-cell lymphoma Diffuse large B-cell lymphoma refractory Dilated cardiomyopathy Dyslipidaemia EGFR gene mutation Emphysema End stage renal disease Endometrial cancer Endotracheal intubation Enuresis Ependymoma Epileptic encephalopathy Epstein-Barr virus associated lymphoma Essential thrombocythaemia Ewing's sarcoma Ewing's sarcoma metastatic Ewing's sarcoma recurrent Extra-osseous Ewing's sarcoma Extra-osseous Ewing's sarcoma metastatic Extra-osseous Ewing's sarcoma recurrent Facioscapulohumeral muscular dystrophy Factor IX deficiency Factor VIII deficiency Familial hypertriglyceridaemia Follicle centre lymphoma follicular grade I, II - III Follicle centre lymphoma follicular grade I, II - III recurrent Follicular lymphoma Fungal infection Gallbladder cancer Gastric cancer Gastrointestinal carcinoma Gastrointestinal stromal tumour Gastrooesophageal cancer General anaesthesia Glioblastoma Glioblastoma multiforme Glomerulonephritis membranoproliferative Glomerulonephritis membranous Glomerulonephritis rapidly progressive Glucose tolerance impaired Glycogen storage disease type II Granulomatosis with polyangiitis Group B streptococcus neonatal sepsis Guillain-Barre syndrome Haematological malignancy Haemodialysis Haemophilia A with anti factor VIII Haemophilia B with anti factor IX Haemorrhage Hand dermatitis Head and neck cancer Heart valve operation Hepatic cancer recurrent Hepatic cirrhosis Hepatitis B Hepato-lenticular degeneration Hepatocellular carcinoma Hereditary motor and sensory neuropathy Herpes simplex meningitis Hidradenitis High-grade B-cell lymphoma HIV infection Hodgkin's disease Hormone receptor positive HER2 negative breast cancer Hormone-refractory prostate cancer Hyperchylomicronaemia Hyperglycaemia Hyperparathyroidism primary Hypertension Hypertonic bladder Hypertriglyceridaemia Hypertrophic cardiomyopathy Hypocalcaemia Hypoparathyroidism Hypotension Hypothyroidism Idiopathic pulmonary fibrosis IgA nephropathy Immunodeficiency congenital Implant site infection Incontinence Infection Infectious pleural effusion Influenza Insulin resistance Insulin-requiring type 2 diabetes mellitus Intensive care Interstitial lung disease Intervertebral disc degeneration Intestinal infarction Intestinal obstruction Iron deficiency Ischaemic stroke Juvenile idiopathic arthritis Juvenile psoriatic arthritis K-ras gene mutation Kidney transplant rejection Klinefelter's syndrome Laparotomy Leiomyosarcoma Liposarcoma Liposarcoma metastatic Low anterior resection syndrome Lupus nephritis Malignant fibrous histiocytoma Malignant glioma Malignant lymphoid neoplasm Malignant melanoma Malignant melanoma stage III Malignant neoplasm of ampulla of Vater Mantle cell lymphoma Mantle cell lymphoma stage II Mantle cell lymphoma stage III Mantle cell lymphoma stage IV Marginal zone lymphoma Medulloblastoma Meningococcal infection Metabolic dysfunction-associated liver disease Metabolic dysfunction-associated steatohepatitis Metastatic malignant melanoma Metastatic renal cell carcinoma Microscopic polyangiitis Migraine Monogenic diabetes Multifocal motor neuropathy Multiple sclerosis Multiple sclerosis relapse Multiple system atrophy Myasthenia gravis Myelodysplastic syndrome Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome Myelofibrosis Myocardial infarction Myocardial ischaemia Myotonic dystrophy Narcolepsy Neoplasm malignant Neovascular age-related macular degeneration Nephroblastoma Nephrogenic anaemia Nephrotic syndrome Neuroblastoma Neurodermatitis Neuroendocrine carcinoma Neuroendocrine tumour Neurogenic bladder Neuropathic arthropathy Neuropathy peripheral Non-alcoholic steatohepatitis Non-Hodgkin's lymphoma Non-obstructive cardiomyopathy Non-small cell lung cancer Non-small cell lung cancer metastatic Non-small cell lung cancer recurrent Non-small cell lung cancer stage IV Obesity Ocular myasthenia Oesophageal adenocarcinoma stage II Oesophageal adenocarcinoma stage III Oesophageal carcinoma Oesophageal squamous cell carcinoma Oesophageal squamous cell carcinoma stage II Oesophageal squamous cell carcinoma stage III Oesophagectomy Osteoarthritis Osteogenesis imperfecta Osteomyelitis Osteoporosis Osteoporosis postmenopausal Osteosarcoma Ovarian cancer Ovarian cancer stage III Ovarian epithelial cancer Overweight Pain in extremity Pancreatic carcinoma Pancreatic carcinoma metastatic Pancreatic carcinoma recurrent Paranasal sinus inflammation Parkinson's disease Partial seizures Peritoneal dialysis Peritonitis Petit mal epilepsy Plasma cell myeloma Plasma cell myeloma refractory Pleural mesothelioma Pneumonia Poisoning Polymyalgia rheumatica Polymyositis Prader-Willi syndrome Precocious puberty Primary amyloidosis Primary biliary cholangitis Primary immunodeficiency syndrome Primary progressive multiple sclerosis Procedural pain Prodromal Alzheimer's disease Progressive multiple sclerosis Prostate cancer Prostate cancer metastatic Prostate cancer recurrent Proteinuria Psoriasis Psoriatic arthropathy Pulmonary arterial hypertension Pulmonary hypertension Pyruvate kinase deficiency anaemia Radius fracture Rectal cancer Relapsing multiple sclerosis Relapsing-remitting multiple sclerosis Renal cell carcinoma Renal cell carcinoma stage IV Renal failure Renal transplant Retinal artery occlusion Rhabdomyosarcoma Rheumatoid arthritis Salivary gland cancer Sarcoidosis Sarcoma Schizophrenia Secondary immunodeficiency Secondary progressive multiple sclerosis Sepsis Septic shock Severe myoclonic epilepsy of infancy Shock Sinusitis noninfective Sjogren's syndrome Somatic symptom disorder Spinal muscular atrophy Splenic marginal zone lymphoma Squamous cell carcinoma of head and neck Status epilepticus Stomatitis Stress cardiomyopathy Stress urinary incontinence Systemic lupus erythematosus Systemic scleroderma T-cell lymphoma Tertiary adrenal insufficiency Thalassaemia alpha Thalassaemia beta Thrombocytopenia Thrombosis prophylaxis Tooth disorder Transcatheter aortic valve implantation Transient ischaemic attack Transitional cell carcinoma Triple negative breast cancer Tuberculosis Tubulointerstitial nephritis Turner's syndrome Type 1 diabetes mellitus Type 2 diabetes mellitus Type IIa hyperlipidaemia Urinary incontinence Uveal melanoma Vaginal haemorrhage Varicella Vestibular disorder VEXAS syndrome Von Hippel-Lindau disease Vulvovaginal discomfort Vulvovaginal dryness Vulvovaginal pain Vulvovaginal pruritus Waldenstrom's macroglobulinaemia

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!